لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Tran HT; University of Texas MD Anderson Cancer Center, Houston, TX., Lam VK; University of Texas MD Anderson Cancer Center, Houston, TX., Elamin YY; University of Texas MD Anderson Cancer Center, Houston, TX., Hong L; University of Texas MD Anderson Cancer Center, Houston, TX., Colen R; University of Texas MD Anderson Cancer Center, Houston, TX., Elshafeey NA; University of Texas MD Anderson Cancer Center, Houston, TX., Hassan ISA; University of Texas MD Anderson Cancer Center, Houston, TX., Altan M; University of Texas MD Anderson Cancer Center, Houston, TX., Blumenschein GR; University of Texas MD Anderson Cancer Center, Houston, TX., Rinsurongkawong W; University of Texas MD Anderson Cancer Center, Houston, TX., Rivera MJ; University of Texas MD Anderson Cancer Center, Houston, TX., Vasquez ME; University of Texas MD Anderson Cancer Center, Houston, TX., Carter BW; University of Texas MD Anderson Cancer Center, Houston, TX., Byers LE; University of Texas MD Anderson Cancer Center, Houston, TX., Tsao AS; University of Texas MD Anderson Cancer Center, Houston, TX., Gibbons DL; University of Texas MD Anderson Cancer Center, Houston, TX., Fossella F; University of Texas MD Anderson Cancer Center, Houston, TX., Glisson BS; University of Texas MD Anderson Cancer Center, Houston, TX., Zhang J; University of Texas MD Anderson Cancer Center, Houston, TX., Heymach JV; University of Texas MD Anderson Cancer Center, Houston, TX.

المصدر: JCO precision oncology [JCO Precis Oncol] 2021 Aug 05; Vol. 5. Date of Electronic Publication: 2021 Aug 05 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung/*blood , Circulating Tumor DNA/*blood , Genes, erbB/*genetics , Lung Neoplasms/*blood , Protein Kinase Inhibitors/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/genetics ; Drug Resistance, Neoplasm/genetics ; ErbB Receptors/genetics ; Female ; Gene Frequency ; Genomics ; High-Throughput Nucleotide Sequencing ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Male ; Middle Aged ; Mutation ; Progression-Free Survival ; Retrospective Studies